UNSPSC 85892560: High dose rate (hdr) brachytherapy of left breast using californium 252 (cf-252)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of left breast using californium 252 (cf-252). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DM109CZ

UNSPSC 85892560 High dose rate brachytherapy of left breast using californium 252 (Commodity) shows minimal recent state and local procurement activity aligned with its nominal scope. The single recent opportunity in the source, a Santa Clara County Health System RFQ posted July 7, 2026 (RFSQHHSFY270052) with responses due October 7, 2026, solicits temporary health professional staffing services across ancillary clinical categories including audiology, cardiology, diagnostic imaging, gastroenterology, ophthalmology, orthopedic, respiratory care, sterile processing, and surgical services — a scope materially distinct from the specialized oncology treatment the code describes. The Health System established a multiple-award qualified vendor pool for temporary placement rather than procurement of a specific clinical service or equipment. The Health System excludes nursing, physician, and non-clinical staffing from the solicitation.

The mismatch between the code's stated focus on high-dose-rate brachytherapy with californium-252 and the actual staffing-services work being solicited suggests either a coding error in the opportunity posting or limited genuine procurement activity under this Commodity code within state and local government. The Santa Clara County Health System solicitation, while representative of the single available record, does not reflect specialized radiotherapy procurement. No geographic spread across multiple jurisdictions or representative brachytherapy-related opportunities emerge from the source. Business development professionals should verify whether this code regularly routes cancer-treatment procurement or whether the staffing opportunity represents a data-entry anomaly. Absence of aligned opportunities at this code level warrants close tracking to detect when actual brachytherapy equipment or clinical-physics services enter the state and local market.